Merger-killing ego: does it strangle Indian pharma superpower ambitions before birth?
This article was originally published in Scrip
Executive Summary
"Despite all the seeming cultural and other issues, if Dr Anji Reddy [the founder of Dr Reddy's Laboratories] and Dr Yusuf Hamied [Cipla's chairman and managing director] can come together and merge their businesses, it will be a great day not only for Indian pharma but for the country." So says Dr Brian Tempest, an ex-CEO of Ranbaxy Laboratories and currently an advisor to MAPE, a mid-market investment bank, and the United Nations Conference on Trade and Development, among other positions.